Frontiers in cardiovascular medicine and science -1 HFpEF
Frontiers in cardiovascular medicine and science -1 HFpEF
09/23 08:30-11:40
频道13
-
-
08:30-08:40
-
09:10-09:40SGLT2 inhibition for HFpEF: the results of the EMPEROR-Preserved trialSGLT2 inhibition for HFpEF: the results of the EMPEROR-Preserved trial
-
08:40-09:10HFpEF: Malady, Model, Meta-inflammatory MechanismsHFpEF: Malady, Model, Meta-inflammatory Mechanisms
-
09:40-10:10Treating Cardiometabolic Syndrome with PDE9 InhibitionTreating Cardiometabolic Syndrome with PDE9 Inhibition
-
10:10-10:40Treatment of HFpEF: A Precision Medicine ApproachTreatment of HFpEF: A Precision Medicine Approach
-
10:40-11:10Metabolic Reprogramming in HFpEF Revealed by Single Cell SequencingMetabolic Reprogramming in HFpEF Revealed by Single Cell Sequencing
-
11:10-11:40Mechanisms of Cardiometabolic Heart Failure with Preserved Ejection Fraction (HFpEF)Mechanisms of Cardiometabolic Heart Failure with Preserved Ejection Fraction (HFpEF)